Compare GABC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GABC | PRGO |
|---|---|---|
| Founded | 1910 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 1995 | 2013 |
| Metric | GABC | PRGO |
|---|---|---|
| Price | $49.77 | $13.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $47.67 | $19.33 |
| AVG Volume (30 Days) | 94.6K | ★ 2.3M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | 2.88% | ★ 10.28% |
| EPS Growth | ★ 8.13 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $487,401,000.00 | $800,000.00 |
| Revenue This Year | $16.78 | N/A |
| Revenue Next Year | $3.98 | $1.02 |
| P/E Ratio | $26.18 | ★ N/A |
| Revenue Growth | ★ 37.80 | N/A |
| 52 Week Low | $37.19 | $9.23 |
| 52 Week High | $52.23 | $22.65 |
| Indicator | GABC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 51.20 |
| Support Level | $48.85 | $13.58 |
| Resistance Level | $51.97 | $13.89 |
| Average True Range (ATR) | 0.80 | 0.58 |
| MACD | -0.05 | -0.22 |
| Stochastic Oscillator | 69.15 | 10.03 |
German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.